美国透析患者心包炎与心包积液住院趋势(2016-2021)
该回顾性队列研究基于美国全国住院患者样本(NIS)2016-2021年数据,分析透析依赖的肾衰竭成人因心包炎或心包积液的住院情况。共识别18,535例样本住院,代表92,675次非联邦急性护理住院。
要点
- 透析患者心包炎/心包积液住院率从2016年2.3/100人年升至2021年3.5/100人年。
- 心包填塞或休克见于11.1%的住院,心包引流操作占13.1%,院内死亡7.8%。
核心结论
- 透析患者因心包炎或心包积液的住院近年增加,心包引流操作相应增加。
- 超过十分之一的住院并发心包填塞或休克。
研究设计与样本
- 回顾性队列研究,使用美国全国住院患者样本(NIS)2016-2021年数据,覆盖约20%非联邦急性护理住院。
- 纳入透析依赖的肾衰竭成人,通过行政编码识别心包炎或心包积液,样本住院18,535例,代表92,675次住院(95%CI 90,674-94,676)。
主要发现
- 住院患者平均年龄57岁,女性占49%。
- 心包填塞或休克诊断占11.1%(95%CI 10.6-11.6),心包引流操作占13.1%(95%CI 12.6-13.6),院内死亡占7.8%(95%CI 7.4-8.2)。
- 住院例数平均每年增加1,370例(95%CI 1,108-1,631;P<0.001),经皮引流操作平均每年增加131例(95%CI 15-246;P=0.04)。
- 住院率从2016年2.3/100人年(95%CI 2.2-2.4)升至2021年3.5/100人年(95%CI 3.4-3.7)(趋势P=0.001)。
临床怎么用
- 透析患者出现心包炎或心包积液时,需警惕心包填塞或休克(约11.1%),并评估心包引流指征。
- 关注住院费用增长趋势,优化资源使用。
局限性
- 基于行政数据,可能存在编码偏倚和漏诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Pericarditis and pericardial effusions may complicate the clinical course of people with kidney failure receiving dialysis. However, few recent data exist on their incidence or associated outcomes and costs. This study characterized hospitalizations among a nationally representative set of US patients receiving maintenance dialysis who experienced pericarditis or pericardial effusion. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Adults with dialysis-dependent kidney failure, represented in the National Inpatient Sample (NIS) (2016-2021), a database of ∼20% of nonfederal acute care hospitalizations in the United States, with pericarditis or pericardial effusions identified using administrative codes. EXPOSURE: Calendar year, pericardial drainage procedures, and cardiac tamponade or cardiogenic shock. OUTCOME: Trends in in-hospital mortality, costs, and repeat pericardial drainage procedures. ANALYTICAL APPROACH: Survey methods with weighted least squares regression to characterize trends. Logistic regression for the risk of repeat pericardial drainage. In-hospital mortality was characterized as a proportion of hospital stays. Cost estimation was based on hospitalization charges and cost-to-charge ratios. RESULTS: We identified 18,535 hospitalizations in the NIS sample, representing a total of 92,675 (95% CI, 90,674-94,676) nonfederal acute care hospital stays. The mean age was 57 years, and 49% were female. Pericardial tamponade or shock was diagnosed in 11.1% (95% CI, 10.6-11.6) of hospitalizations, pericardial drainage procedures were performed in 13.1% (95% CI, 12.6-13.6%), and in-hospital mortality was 7.8% (95% CI, 7.4-8.2%). The counts of hospitalizations increased by an average of 1,370 (95% CI, 1,108-1,631; P < 0.001) per year and percutaneous drainage procedures by an average of 131 (95% CI, 15-246; P = 0.04) per year. The rate of hospitalization increased from 2.3 (95% CI, 2.2-2.4) per 100 person-years in 2016 to 3.5 (95% CI, 3.4-3.7) in 2021 (P for trend = 0.001). Hospital costs increased from $347 million (95% CI, $316-378 million) in 2016 to $591 million (95% CI, $545-637 million) in 2021 (P = 0.001). LIMITATIONS: Administrative data. CONCLUSIONS: Hospitalizations for pericarditis or pericardial effusion among patients on dialysis have increased in recent years, with a corresponding increase in pericardial drainage procedures. More than 1 in 10 hospitalizations were complicated by tamponade or shock. Identifying actionable drivers of the increase in this morbidity over time warrants further investigation. PLAIN-LANGUAGE SUMMARY: Inflammation of the connective tissue lining the heart (pericarditis) and accumulation of fluid around the heart (pericardial effusion) can occur in people who receive dialysis for kidney failure. However, little is known about how often this occurs in recent years or the related outcomes and costs. This study estimated how often hospitalizations with pericarditis or pericardial effusion in people with kidney failure on dialysis occur in the United States. We found that the number of hospitalizations with these problems and procedures to treat them have increased from 2016 to 2021. Additionally, the total cost of these hospitalizations increased from 2016 to 2021. The reasons for the observed increases are uncertain and warrant further study.
引用
- Walther CP, Sarnak MJ, Kayani WT, et al. Hospitalizations With Pericarditis and Pericardial Effusions in People With Kidney Failure Receiving Dialysis in the United States (2016-2021). Am J Kidney Dis. 2026. PMID: 42471176. doi:10.1053/j.ajkd.2026.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。